DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

LinksSchließen

Referenz

Griffith DE, Eagle G, Thomson R. et al; CONVERT Study Group.
Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT): a prospective, open-label, randomized study.

Am J Respir Crit Care Med 2018;
198 (12) 1559-1569

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: